These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13001631)

  • 1. PREVENTING measles.
    Med World; 1952 Oct; 77(5):117-8. PubMed ID: 13001631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of specific serum prophylaxis in the South Greenland measles epidemic 1951].
    CHRISTENSEN PE; SCHMIDT H
    Ugeskr Laeger; 1953 May; 115(20):779-86. PubMed ID: 13077992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Attempted prevention of measles by means of intra-ocular instillation of convalescent sera. Preliminary communication].
    JAROSZYNSKA-WEINBERGER B
    Pediatr Pol; 1960 Mar; 35():345-52. PubMed ID: 14406839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measles prevention--past and future].
    Huber HG
    Kinderarztl Prax; 1969 Oct; 37(10):461-71. PubMed ID: 4904333
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spread of measles, chickenpox & mumps checked by a new method of prevention in a 200-bed sanatorium for children].
    RUSTI J
    Rev Immunol Ther Antimicrob; 1957; 21(5-6):393-6. PubMed ID: 13528251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biorecon in prevention of cross-infection in hospitals].
    LAWRENZ KH
    Kinderarztl Prax; 1954 Sep; 22(9):406-8. PubMed ID: 13234181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Research on the antigenic properties of renin. 3. Behavior of the precipitation reaction in agar between anti-renin immune serums and renal extracts with renin activity subjected to inactivation procedures. Study of the relations between neutralizing power and precipitating activity of antirenin immune serums].
    Semprini A; Ravetta M; Tallarida G; Leone G; Peschle C; Condorelli M
    Boll Soc Ital Biol Sper; 1967 Jun; 43(12):671-4. PubMed ID: 4965944
    [No Abstract]   [Full Text] [Related]  

  • 8. Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187.
    Zingher A; Mortimer P
    Rev Med Virol; 2005; 15(6):407-18; discussion 418-21. PubMed ID: 16211552
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologically specific antigens in leukemic tissues.
    GREENSPAN I; BROWN ER; SCHWARTZ SO
    Blood; 1963 Jun; 21():717-28. PubMed ID: 13950201
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research on the neurohumoral regulation of circulation. Inhibition of the hypertensive actvity of placental protein extracts by antirenin immune serums].
    Tallarida G; Cassone R; Semprini A; Baldoni F
    Boll Soc Ital Biol Sper; 1971 Sep; 47(17):508-12. PubMed ID: 4400905
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-cancerous activity and specificity of anti-embryonal serums].
    Sédallian JP
    C R Seances Soc Biol Fil; 1966; 160(11):2092-6. PubMed ID: 4228139
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on the neuro-humoral regulation of circulation. Study of the precipitation reaction in agar between placental extracts with hypertensive renin-like activity and anti-renin immune serums].
    Semprini A; Tallarida G; Baldoni F; Cassone R
    Boll Soc Ital Biol Sper; 1971 Sep; 47(18):513-7. PubMed ID: 4400929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preparation of anti-H-salmonella agglutinating serums].
    Vlădoianu IR; Mitrică N; Dimache G
    Prog Immunobiol Stand; 1970; 4():571-4. PubMed ID: 4921392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methods for obtaining carcinoembryonic immune serums from colonic tumors].
    Luzzi M; Depieds R
    Ann Inst Pasteur (Paris); 1972 Feb; 122(2):341-58. PubMed ID: 4625724
    [No Abstract]   [Full Text] [Related]  

  • 15. An immunological study of subacute sclerosing panencephalitis: measles and tissue antigens and immunoglobulins.
    Bernard D; Ripert G; Haddad A; Riberi M; Depieds R
    Ann Immunol (Paris); 1974; 125(3):461-89. PubMed ID: 4137536
    [No Abstract]   [Full Text] [Related]  

  • 16. The present prophylactic trends of rubella and measles.
    Zardi O; Soubotian B
    Biochem Exp Biol; 1979; 15(3):223-8. PubMed ID: 555675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
    Julik E; Reyes-Del Valle J
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles modification; the rational employment of immune serum globulin.
    HELLER G
    J Med Soc N J; 1952 Nov; 49(11):481-2. PubMed ID: 13000319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
    Zverev VV; Iuminova NV
    Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs of preventing measles.
    Sloan D
    JAMA; 1992 Feb; 267(5):656. PubMed ID: 1731131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.